4//SEC Filing
Seltzer Stacey Denenberg 4
Accession 0000950142-17-002181
CIK 0001631650other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:31 PM ET
Size
5.2 KB
Accession
0000950142-17-002181
Insider Transaction Report
Form 4
Seltzer Stacey Denenberg
Director
Transactions
- Other
Common Stock
2017-12-06+29→ 29 total
Footnotes (1)
- [F1]On December 6, 2017, Aisling Capital III, LP and certain of its affiliated funds distributed a portion of the shares of common stock of the Issuer (the "Common Stock") beneficially owned by such funds to their partners for no consideration. In connection with the distributions, the reporting person received 29 shares of Common Stock. In accordance with Rule 16a-9, such acquisition is exempt from Section 16 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
Related Parties
1- filerCIK 0001648895
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 4:31 PM ET
- Size
- 5.2 KB